Swedencare AB · OMXSTO:SECARE
Swedencare AB — Investor Presentation (September 2022)
26 slides from Swedencare AB's investor presentation, September 2022
Slide 1: Presentation of Swedencare
Presentation of Swedencare
Slide 2: What we are
What we are Global Entrepreneurial Fast growing Cash flow Profitable positive Our values Demand Agile Caring Professional M&A active =Launches
Slide 3: Our story
Our story • The story of Swedencare begins in the 1970s, when Swedish dentist Dr. Sune Wikner discovered that a patient eating a diet rich in a certain type of seaweed had substantially managed to reduce the formation of tartar and plaque. • As a result of this unique finding, Dr. Sune Wikner and Ro
Slide 4: Our story
Our story • In 2020 Stratford, Animal Pharmaceuticals and Nutravet were acquired. The acquisitions significantly strengthened our presence in the veterinary and digital channels, as well as our position in North America, the largest pet market in the world. • In 2021, Pet MD Brands, a state-of-the-a
Slide 5: Swedencare at a glance
Swedencare at a glance ANIMAL Pharmaceuticals PlaqueOff Own production Companion Strong is : j animals Offices in growth 9 —.. 2016 2017 2018 Countries 2019 2020 2021 2022 Wide product range Wide channel range Proforma 2021 Not revenue 1 632 MSEK EBITDA-margin 28%
Slide 6: From pet oral health to animal health company
Oral Stress Joints Skin & Coat Gastro PET SHOPS Immune Wellbeing Brain Liver Probiotics Ears Derma & Grooming Wounds Urinary tract Kidneys Heart Allergies Behaviour Pain Eyes petmdstore.com Stress Joints Coat Gastro Immune Recovery Probiotics From pet oral health to animal health company Hoofs Muscl
Slide 7: Swedencare's value chain
Swedencare’s value chain SG *® B
Slide 8: Swedencare's M&A Strategy
Swedencare’s M&A Strategy Swedencare´s M&A Strategy We seek companies that are similar to ours in that they should be entrepreneurial, profitable and with potential for high growth rate. The owners/management should share our vision in creating a world leading group within the Pet Healthcare market
Slide 9: M&A Timeline
M&A Timeline Nutriscience (2016 Holden2 (2020 NaturVet(2022) BAe tern eet 2 I ™ (C Vetio(2021)_} Stratford (2020 {Animal Pharmaceuticals (2020) } { InnoVet (2022) )
Slide 10: Pet Industry - a booming market
Pet Industry - a booming market Triple growth from $100 billion to $275 billion by 2030* KEY DRIVERS: New owners Increased pet spending Favorable demographics It should be noted that the source used a new research methodology from 2018, therefore, direct comparisons to previous years should be avoid
Slide 11: New owners
New owners 69% of respondents "strongly agree" that their pets are important members of the Two thirds of U.S households have at least one pet family* • In 2020 nearly 70% of American households owned one or more pets - in comparison to 56% pet ownership rate in 1988 • Expected 14% increase in pet o
Slide 12: Increased pet spending
45% of American pet owners spend the same Increased pet spending amount of money or more on their pets’ healthcare as they do on their own** • US spending on pet care and products has seen an even greater rise over the past few decades, both overall and on a per capita basis • Average annual expense
Slide 13: Favorable demographics
Favorable demographics More than half of millennial pet owners Millennials buy their pets gifts at least once a month** • Millennials are the largest age group of pet owners in the US, with 32% of them owning at least one**. • 65% of 18- to 34-year-olds plan to acquire or add a pet in the next five
Slide 14: Top 5 trends in Pet Care
Top 5 trends in Pet Care 71% of pet owners consider their pets as family members Consumers are searching for treats which are close Humanisation to human grade Pet parents are increasingly eager to provide their Premiumisation pets with high quality, expensive food and products Health & Wellness Inc
Slide 15: Swedencare's Sustainability work
Swedencare´s Sustainability work Swedencare's ambition is that the environmental work should be a natural part of our entire business. We are aware that while we contribute to development and prosperity, we are also a threat to the environment. Swedencare works to ensure that our companies, our empl
Slide 16: Ownership structure per latest quarterly report – Q2 2022
Ownership structure per latest quarterly report – Q2 2022 Shareholders Number of shares Ownership Symrise AG 47 117 318 29,8% Håkan Svanberg & Co Health Care AB 23 017 275 14,6% JCC Group Invest Sweden AB (Johan Bergdahl through company) 7 526 755 4,8% AMF Aktiefond Småbolag 6 006 500 3,8% Mastan AB
Slide 17: Key Performance Indicators
Key Performance Indicators H1 2022
Slide 18: Sales per region H1
Sales per region H1 REST OF THE WORLD 1% 6% 2% NORTH AMERICA NORTH AMERICA 80% 62% ~—
Slide 19: Sales per product category H1
Sales per product category H1
Slide 20: Sales per brand Q2
Sales per brand Q2 omen nutravet* 14% 3% Pet MD 8 SWEDENCARE
Slide 21: Rolling Quarters
Rolling 4 Quarters 300 1 200 1 100 1 000 900 —— tt oh & & & Qi a2 03 a4 Q1 G2 QO 4 Qi G2 QO G4 AI QQ 2019 2020 2021 2022 ME Net Revenue MEESITDA =—_ EEN Operational EBITDA 8 SWEDENCARE
Slide 22: Priorities 2022/2023
Priorities 2022/2023 • Pet market 6-7% Supplements/RX 10-12% SWEDENCARE +20% • 2022/2023 - SYNERGIES Short term • Expanding of new products/brands on new markets with current presence and in new channels • Skilled & cost-efficient marketing campaigns • Cooperation between entities for R&D and shared
Slide 23: Swedencare's legal organizational chart
Swedencare´s legal organizational chart
Slide 24: Board of Directors
Board of Directors Responsible for the Company’s strategic, financial targets and, together with the management, for the strategic planning. Extensive experience of international sales, marketing as well as a wide international network. Håkan Svanberg* - President of the board since 2022 Johan Bergd
Slide 25: Management
Management • Responsible to provide a business plan in line with the BoDs strategic and financial targets. Responsible for financial planning, questions and communication with the stock exchange. The CEO of the Company, together with the managing directors of the subsidiaries, are responsible for pr
Slide 26: Vision Mission
Vision Our vision is to establish ourselves as the leading company within Pet Health Care on all larger markets. Mission We care about improving the health and wellbeing of pets, creating reassurance for the pet parents, worldwide and throughout life.